EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CRISPR-Cas9-driven antigen conversion of clinically relevant blood group systems

Yelena Boccacci, Nellie Dumont, Yannick Doyon, Josée Laganière

Human Molecular Genetics · 04.06.2025 · 34 (12) · 1001-1008

DOI: 10.1093/hmg/ddaf040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Molecular Genetics, online erschienen am 02.04.2025. Verfasst von Yelena Boccacci und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre Hospitalier Universitaire de Québec Research Center - Université Laval, 2705 boulevard Laurier, Québec, QC G1V 4G2, Canada. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Blood Group Antigens, ABO Blood-Group System. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Centre de recherche du CHU de Québec-Université Laval, Faculté de médecine de l'Université Laval, Mitacs and Héma-Québec, Centre de recherche du CHU de Québec—Université Laval.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The common practice of blood transfusion entirely relies on blood donations from the population. Ensuring blood group compatibility between a donor and a recipient is paramount to prevent critical adverse reactions. Finding compatible blood can be challenging given the high diversity of blood group antigens, especially for chronically transfused patients at higher risk of alloimmunization owing to repeated exposures to foreign RBCs. In addition, due to the immunogenicity of the ABO blood group and the highly polymorphic nature of the Rhesus (Rh) system, they both remain of prime importance in transfusion medicine. Cultured red blood cells (cRBCs) may eventually provide an alternative for blood donations—at least in some circumstances. Combining cRBCs with blood group gene editing could broaden transfusion accessibility by making antigen expression compatible with rare phenotypes, thus meeting the needs of more patients. Starting from mobilized, erythroid-primed hematopoietic stem and progenitor cells (HSPCs), we used virus- and selection-free, CRISPR-Cas9-mediated knockouts to produce erythroid cells devoid of AB and Rh antigen. The approach yielded almost complete conversion to O- and RhNull phenotypes, as determined by standard hemagglutination and flow cytometry analyses. Combined with robust cRBC protocols, these clinically relevant phenotypic changes could eventually expand the accessibility of blood transfusion for specific and unmet clinical needs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsBlood Group AntigensABO Blood-Group SystemHumansGene EditingErythrocytesRh-Hr Blood-Group SystemHematopoietic Stem CellsBlood Transfusion

Stichwörter der Autor:innen

CRISPR-Cas9blood groupserythroid progenitorsgene editinghematopoietic stem and progenitor cells

Substanzen

Blood Group AntigensABO Blood-Group SystemRh-Hr Blood-Group System

Autor:innen und Institutionen

  • Centre Hospitalier Universitaire de Québec Research Center - Université Laval, 2705 boulevard Laurier, Québec, QC G1V 4G2, Canada.
  • Faculty of Medicine, Laval University, 1050 avenue de la Médecine, Québec, QC G1V 0A6, Canada.
  • Université Laval Cancer Research Centre, 1050 avenue de la Médecine, Québec, QC G1V 0A6, Canada.
  • Medical Affairs and Innovation, Héma-Québec, 1070 avenue des Sciences-de-la-Vie, Québec, QC G1V 5C3, Canada.

Förderung

  • Centre de recherche du CHU de Québec-Université Laval
  • Faculté de médecine de l'Université Laval, Mitacs and Héma-Québec
  • Centre de recherche du CHU de Québec—Université Laval

Zitieren

APA

Boccacci, Y., Dumont, N., Doyon, Y., & Laganière, J. (2025). CRISPR-Cas9-driven antigen conversion of clinically relevant blood group systems. Human Molecular Genetics, 34(12), 1001-1008. https://doi.org/10.1093/hmg/ddaf040

Vancouver

Boccacci Y, Dumont N, Doyon Y, Laganière J. CRISPR-Cas9-driven antigen conversion of clinically relevant blood group systems. Human Molecular Genetics. 2025;34(12):1001-1008. doi:10.1093/hmg/ddaf040

BibTeX
@article{Boccacci2025,
  author = {Boccacci, Yelena and Dumont, Nellie and Doyon, Yannick and Laganière, Josée},
  title = {CRISPR-Cas9-driven antigen conversion of clinically relevant blood group systems},
  journal = {Human Molecular Genetics},
  year = {2025},
  volume = {34},
  number = {12},
  pages = {1001--1008},
  doi = {10.1093/hmg/ddaf040}
}
Kostenlos starten →